These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 9380524)

  • 21. Guanine-rich sequences inhibit proofreading DNA polymerases.
    Zhu XJ; Sun S; Xie B; Hu X; Zhang Z; Qiu M; Dai ZM
    Sci Rep; 2016 Jun; 6():28769. PubMed ID: 27349576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved LM-PCR procedure for in vivo footprinting analysis of GC-rich promoters.
    Le Cam L; Polanowska J; Fajas L; Fabbrizio E; Sardet C
    Biotechniques; 1999 May; 26(5):840-3. PubMed ID: 10337472
    [No Abstract]   [Full Text] [Related]  

  • 23. A rapid and simple method for the detection of prostate-specific antigen mRNA in archival tissue specimens using a reverse transcription-polymerase chain reaction assay.
    Edelstein RA; Krane RJ; Babayan RK; de las Morenas A; Moreland RB
    Urology; 1995 Apr; 45(4):597-603. PubMed ID: 7536367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PDGF B mRNA variants in human tumors with similarity to the v-sis oncogene: expression of cellular PDGF B protein is associated with exon 1 divergence, but not with a 3'UTR splice variant.
    Heller S; Scheibenpflug L; Westermark B; Nistér M
    Int J Cancer; 2000 Jan; 85(2):211-22. PubMed ID: 10629080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PCR amplification of GC-rich DNA regions using the nucleotide analog N4-methyl-2'-deoxycytidine 5'-triphosphate.
    Flores-Juárez CR; González-Jasso E; Antaramian A; Pless RC
    Biotechniques; 2016 Oct; 61(4):175-182. PubMed ID: 27712580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of an improved cDNA competition technique to identify prostate cancer-associated gene.
    Rinaldy AR; Steiner MS
    DNA Cell Biol; 1999 Nov; 18(11):829-36. PubMed ID: 10595396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A primer design strategy for PCR amplification of GC-rich DNA sequences.
    Li LY; Li Q; Yu YH; Zhong M; Yang L; Wu QH; Qiu YR; Luo SQ
    Clin Biochem; 2011 Jun; 44(8-9):692-8. PubMed ID: 21315705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application for PCR technology to subtractive cDNA cloning: identification of genes expressed specifically in murine plasmacytoma cells.
    Timblin C; Battey J; Kuehl WM
    Nucleic Acids Res; 1990 Mar; 18(6):1587-93. PubMed ID: 2326198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of differentially expressed genes using RNA fingerprinting by arbitrarily primed polymerase chain reaction.
    Mathieu-Daudé F; Trenkle T; Welsh J; Jung B; Vogt T; McClelland M
    Methods Enzymol; 1999; 303():309-24. PubMed ID: 10349652
    [No Abstract]   [Full Text] [Related]  

  • 30. Enzymatic amplification of DNA by PCR: standard procedures and optimization.
    Kramer MF; Coen DM
    Curr Protoc Cytom; 2006 Aug; Appendix 3():Appendix 3K. PubMed ID: 18770830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enrichment of alternatively spliced isoforms.
    Venables JP
    Methods Mol Biol; 2008; 419():161-70. PubMed ID: 18369982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An introduction to PCR primer design and optimization of amplification reactions.
    Robertson JM; Walsh-Weller J
    Methods Mol Biol; 1998; 98():121-54. PubMed ID: 9664560
    [No Abstract]   [Full Text] [Related]  

  • 33. Advantages of mRNA amplification for microarray analysis.
    Feldman AL; Costouros NG; Wang E; Qian M; Marincola FM; Alexander HR; Libutti SK
    Biotechniques; 2002 Oct; 33(4):906-12, 914. PubMed ID: 12398200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alternative splicing of PSP94 (prostatic secretory protein of 94 amino acids) mRNA in prostate tissue.
    Xuan JW; Chin JL; Guo Y; Chambers AF; Finkelman MA; Clarke MW
    Oncogene; 1995 Sep; 11(6):1041-7. PubMed ID: 7566962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amplification of GC-rich Putative Mouse PeP Promoter using Betaine and DMSO in Ammonium Sulfate Polymerase Chain Reaction Buffer.
    Seifi T; Ghaedi K; Salamian A; Tanhaei S; Safari F; Hojati Z; Tavassoli M; Baharvand H; Esfahani MH
    Avicenna J Med Biotechnol; 2012 Oct; 4(4):206-9. PubMed ID: 23408119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients.
    Kurek R; Nunez G; Tselis N; Konrad L; Martin T; Roeddiger S; Aumüller G; Zamboglou N; Lin DW; Tunn UW; Renneberg H
    Clin Cancer Res; 2004 Sep; 10(17):5808-14. PubMed ID: 15355910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple mRNA species are generated by alternate polyadenylation from the human calmodulin-I gene.
    Senterre-Lesenfants S; Alag AS; Sobel ME
    J Cell Biochem; 1995 Aug; 58(4):445-54. PubMed ID: 7593266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymerase chain reaction-mediated mutagenesis in sequences resistant to homogeneous amplification.
    Nazar RN; Abeyrathne PD; Intine RV
    Methods Mol Biol; 2002; 182():117-26. PubMed ID: 11768959
    [No Abstract]   [Full Text] [Related]  

  • 39. Analytical variables of reverse transcription-polymerase chain reaction-based detection of disseminated prostate cancer cells.
    Zippelius A; Lutterbüse R; Riethmüller G; Pantel K
    Clin Cancer Res; 2000 Jul; 6(7):2741-50. PubMed ID: 10914719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of alternatively spliced growth factor receptor isoforms in the human trabecular meshwork.
    Wordinger RJ; Clark AF; Agarwal R; Lambert W; Wilson SE
    Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):242-7. PubMed ID: 9888450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.